# Ken Herrmann

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ken-herrmann/

## Facts

| Field | Value |
| --- | --- |
| Citations | 35,295 |
| Field | Radiopharmaceutical Chemistry and Applications |
| h-index | 97 |
| i10-index | 455 |
| Last Known Institution | German Cancer Research Center |
| OpenAlex ID | https://openalex.org/A5006830341 |
| ORCID iD | https://orcid.org/0000-0002-9662-7259 |
| Works | 973 |

## Researcher papers

- [Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer](https://scholariq.org/papers/lutetium-177-psma-617-for-metastatic-castration-resistant-prostate-cancer/)
- [Assessment of <sup>68</sup>Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer](https://scholariq.org/papers/assessment-of-sup-68-sup-ga-psma-11-pet-accuracy-in-localizing-recurrent/)
- [68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0](https://scholariq.org/papers/68ga-psma-pet-ct-joint-eanm-and-snmmi-procedure-guideline-for-prostate-cancer/)
- [Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT](https://scholariq.org/papers/prostate-cancer-molecular-imaging-standardized-evaluation-promise-proposed-mitnm/)
- [Radiotheranostics in oncology: current challenges and emerging opportunities](https://scholariq.org/papers/radiotheranostics-in-oncology-current-challenges-and-emerging-opportunities/)
- [PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0](https://scholariq.org/papers/psma-pet-ct-joint-eanm-procedure-guideline-snmmi-procedure-standard-for-prostate/)
- [EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)](https://scholariq.org/papers/eanm-procedure-guidelines-for-radionuclide-therapy-with-177lu-labelled-psma/)
- [E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET](https://scholariq.org/papers/e-psma-the-eanm-standardized-reporting-guidelines-v1-0-for-psma-pet/)
- [Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors](https://scholariq.org/papers/appropriate-use-criteria-for-somatostatin-receptor-pet-imaging-in-neuroendocrine/)
- [EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†](https://scholariq.org/papers/eau-esmo-consensus-statements-on-the-management-of-advanced-and-variant-bladder/)
- [Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-metastatic-and-or/)

## Researcher topics

- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Medical Imaging Techniques and Applications](https://scholariq.org/topics/medical-imaging-techniques-and-applications/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

## Researcher university

- [German Cancer Research Center](https://scholariq.org/institutions/german-cancer-research-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.